3M5M
Avoiding drug resistance against HCV NS3/4A protease inhibitors
Summary for 3M5M
| Entry DOI | 10.2210/pdb3m5m/pdb |
| Related | 3M5L 3M5N 3M5O |
| Descriptor | NS3/4A, FDEMEEC Peptide, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, ... (6 entities in total) |
| Functional Keywords | hcv, hepatitis c virus, ns3, protease, drug resistance, serine protease, chimera protein, fusion protein, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
| Biological source | Hepatitis C virus subtype 1a More |
| Total number of polymer chains | 3 |
| Total formula weight | 44516.90 |
| Authors | Schiffer, C.A.,Romano, K.P. (deposition date: 2010-03-12, release date: 2010-11-24, Last modification date: 2017-11-08) |
| Primary citation | Romano, K.P.,Ali, A.,Royer, W.E.,Schiffer, C.A. Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding. Proc.Natl.Acad.Sci.USA, 107:20986-20991, 2010 Cited by PubMed: 21084633DOI: 10.1073/pnas.1006370107 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.7 Å) |
Structure validation
Download full validation report
